SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ou4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	GLY A 86 GLY A 87 GLY A 88 PHE A 207 HIS A 286	None	0.55A	1dx6A-4ou4A: 18.7	1dx6A-4ou4A: 19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	GLY A 86 GLY A 87 GLY A 88 PHE A 216 HIS A 286	None	1.00A	1dx6A-4ou4A: 18.7	1dx6A-4ou4A: 19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FDS_A_ESTA350_1 (17-BETA-HYDROXYSTERO ID-DEHYDROGENASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	VAL A 5 LEU A 13 GLY A 4 PRO A 3 PHE A 255	None	1.48A	1fdsA-4ou4A: 4.2	1fdsA-4ou4A: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KXH_A_ACRA598_1 (ALPHA-AMYLASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	ALA A 159 GLY A 162 ALA A 128 ILE A 64 ASP A 116	None	1.17A	1kxhA-4ou4A: undetectable	1kxhA-4ou4A: 20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SKX_A_RFPA1_2 (ORPHAN NUCLEAR RECEPTOR PXR)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 5	LYS A 173 PHE A 84 LEU A 170 LEU A 315	None	1.43A	1skxA-4ou4A: undetectable	1skxA-4ou4A: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	6 / 12	GLY A 86 GLY A 87 GLY A 88 PHE A 216 PHE A 207 HIS A 286	None	1.00A	1w6rA-4ou4A: 18.7	1w6rA-4ou4A: 19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YA4_B_CTXB2_1 (CES1 PROTEIN)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	PHE A 83 GLY A 86 GLY A 87 LEU A 36 LEU A 100	None	1.34A	1ya4B-4ou4A: 16.8	1ya4B-4ou4A: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ACE_A_ACHA998_0 (ACETYLCHOLINESTERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	GLY A 87 GLY A 88 PHE A 216 PHE A 207 HIS A 286	None	0.92A	2aceA-4ou4A: 18.4	2aceA-4ou4A: 20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HA4_A_ACTA544_0 (ACETYLCHOLINESTERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 8	GLY A 87 GLY A 88 ALA A 159 PHE A 216 HIS A 286	None	0.92A	2ha4A-4ou4A: 5.5	2ha4A-4ou4A: 22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HA4_B_ACTB601_0 (ACETYLCHOLINESTERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 7	GLY A 87 GLY A 88 ALA A 159 PHE A 216 HIS A 286	None	0.94A	2ha4B-4ou4A: 19.1	2ha4B-4ou4A: 22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_A_RALA600_2 (ESTROGEN RECEPTOR)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 5	ASP A 256 MET A 304 LEU A 104 HIS A 97	None	1.29A	2jfaA-4ou4A: undetectable	2jfaA-4ou4A: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_2 (ESTROGEN RECEPTOR)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 5	ASP A 256 MET A 304 LEU A 104 HIS A 97	None	1.30A	2qxsA-4ou4A: undetectable	2qxsA-4ou4A: 20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_2 (ESTROGEN RECEPTOR)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 5	ASP A 256 MET A 304 LEU A 104 HIS A 97	None	1.29A	2qxsB-4ou4A: undetectable	2qxsB-4ou4A: 20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XFH_A_CL6A1413_1 (ERYTHROMYCIN B/D C-12 HYDROXYLASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 6	HIS A 85 ALA A 128 ALA A 132 THR A 136	None	0.93A	2xfhA-4ou4A: undetectable	2xfhA-4ou4A: 22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 8	VAL A 105 VAL A 106 GLY A 109 ARG A 102	None	0.96A	3bjwA-4ou4A: undetectable	3bjwA-4ou4A: 15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LCV_B_SAMB301_0 (SISOMICIN-GENTAMICIN RESISTANCE METHYLASE SGM)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	ARG A 99 THR A 277 ALA A 307 ASP A 103 LEU A 104	None	1.20A	3lcvB-4ou4A: undetectable	3lcvB-4ou4A: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VW7_A_VPXA2001_1 (PROTEINASE-ACTIVATED RECEPTOR 1, LYSOZYME)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	LEU A 208 LEU A 290 LEU A 185 ALA A 156 ALA A 165	None	1.13A	3vw7A-4ou4A: undetectable	3vw7A-4ou4A: 22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	MET A 304 LEU A 104 LEU A 184 GLN A 40 PRO A 188	None	1.33A	3w1wB-4ou4A: 2.5	3w1wB-4ou4A: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OK1_A_198A1001_2 (ANDROGEN RECEPTOR)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 8	LEU A 290 ASN A 158 MET A 212 LEU A 91	None	1.01A	4ok1A-4ou4A: undetectable	4ok1A-4ou4A: 22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 11	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	0.99A	4qvlK-4ou4A: undetectable 4qvlL-4ou4A: undetectable	4qvlK-4ou4A: 21.21 4qvlL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 11	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	0.99A	4qvlY-4ou4A: undetectable 4qvlZ-4ou4A: undetectable	4qvlY-4ou4A: 21.21 4qvlZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	0.99A	4qvmK-4ou4A: undetectable 4qvmL-4ou4A: undetectable	4qvmK-4ou4A: 21.21 4qvmL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 10	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	0.99A	4qvmY-4ou4A: undetectable 4qvmZ-4ou4A: undetectable	4qvmY-4ou4A: 21.21 4qvmZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.02A	4qvnK-4ou4A: undetectable 4qvnL-4ou4A: undetectable	4qvnK-4ou4A: 21.52 4qvnL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.02A	4qvnY-4ou4A: undetectable 4qvnZ-4ou4A: undetectable	4qvnY-4ou4A: 21.52 4qvnZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 10	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.04A	4qvpK-4ou4A: undetectable 4qvpL-4ou4A: undetectable	4qvpK-4ou4A: 21.21 4qvpL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 10	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.04A	4qvpY-4ou4A: undetectable 4qvpZ-4ou4A: undetectable	4qvpY-4ou4A: 21.21 4qvpZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.04A	4qvqK-4ou4A: undetectable 4qvqL-4ou4A: undetectable	4qvqK-4ou4A: 22.26 4qvqL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.03A	4qvqY-4ou4A: undetectable 4qvqZ-4ou4A: undetectable	4qvqY-4ou4A: 22.26 4qvqZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 10	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.04A	4qw1Y-4ou4A: undetectable 4qw1Z-4ou4A: undetectable	4qw1Y-4ou4A: 21.92 4qw1Z-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 10	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	0.99A	4qw3K-4ou4A: undetectable 4qw3L-4ou4A: undetectable	4qw3K-4ou4A: 21.21 4qw3L-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 10	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	0.98A	4qw3Y-4ou4A: undetectable 4qw3Z-4ou4A: undetectable	4qw3Y-4ou4A: 21.21 4qw3Z-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 11	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.01A	5bxnK-4ou4A: undetectable 5bxnL-4ou4A: undetectable	5bxnK-4ou4A: 21.21 5bxnL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 11	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.01A	5bxnY-4ou4A: undetectable 5bxnZ-4ou4A: undetectable	5bxnY-4ou4A: 21.21 5bxnZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.01A	5d0xK-4ou4A: undetectable 5d0xL-4ou4A: undetectable	5d0xK-4ou4A: 21.65 5d0xL-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.00A	5d0xY-4ou4A: undetectable 5d0xZ-4ou4A: undetectable	5d0xY-4ou4A: 21.65 5d0xZ-4ou4A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KOX_A_RFPA502_2 (PENTACHLOROPHENOL 4-MONOOXYGENASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	3 / 3	VAL A 139 ARG A 102 PRO A 71	None	0.76A	5koxA-4ou4A: undetectable	5koxA-4ou4A: 24.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.08A	5l5zK-4ou4A: undetectable 5l5zL-4ou4A: undetectable	5l5zK-4ou4A: 21.57 5l5zL-4ou4A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 9	THR A 252 ALA A 253 GLY A 162 ALA A 159 ASP A 287	None	1.08A	5l5zY-4ou4A: undetectable 5l5zZ-4ou4A: undetectable	5l5zY-4ou4A: 21.57 5l5zZ-4ou4A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N0S_B_SAMB501_1 (PEPTIDE N-METHYLTRANSFERASE)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 4	GLY A 143 ALA A 140 MET A 82 THR A 177	None	1.28A	5n0sB-4ou4A: undetectable	5n0sB-4ou4A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFJ_B_SAMB501_0 (MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	LEU A 208 GLY A 205 LEU A 91 LEU A 24 MET A 212	None	1.02A	5nfjB-4ou4A: undetectable	5nfjB-4ou4A: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFJ_C_SAMC501_0 (MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	5 / 12	LEU A 208 GLY A 205 LEU A 91 LEU A 24 MET A 212	None	1.03A	5nfjC-4ou4A: undetectable	5nfjC-4ou4A: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ODC_F_ACTF503_0 (METHYL-VIOLOGEN REDUCING HYDROGENASE SUBUNIT A)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	4 / 4	ARG A 102 VAL A 106 ASP A 46 LYS A 301	None	1.27A	5odcF-4ou4A: 0.0	5odcF-4ou4A: 21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ODR_D_ACTD202_0 (METHYL-VIOLOGEN REDUCING HYDROGENASE, SUBUNIT D)	4ou4	ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN (Pseudomonas sp. ECU1011)	3 / 3	HIS A 142 GLU A 141 TRP A 138	None	1.14A	5odrD-4ou4A: 2.4	5odrD-4ou4A: 15.96

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DX6_A_GNTA602_1","ACETYLCHOLINESTERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"GLY A  86;GLY A  87;GLY A  88;PHE A 207;HIS A 286","None","0.55A","1dx6A-4ou4A:18.7","1dx6A-4ou4A:19.86"],["1DX6_A_GNTA602_1","ACETYLCHOLINESTERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"GLY A  86;GLY A  87;GLY A  88;PHE A 216;HIS A 286","None","1.00A","1dx6A-4ou4A:18.7","1dx6A-4ou4A:19.86"],["1FDS_A_ESTA350_1","17-BETA-HYDROXYSTEROID-DEHYDROGENASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"VAL A   5;LEU A  13;GLY A   4;PRO A   3;PHE A 255","None","1.48A","1fdsA-4ou4A:4.2","1fdsA-4ou4A:22.01"],["1KXH_A_ACRA598_1","ALPHA-AMYLASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"ALA A 159;GLY A 162;ALA A 128;ILE A  64;ASP A 116","None","1.17A","1kxhA-4ou4A:undetectable","1kxhA-4ou4A:20.76"],["1SKX_A_RFPA1_2","ORPHAN NUCLEAR RECEPTOR PXR","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"LYS A 173;PHE A  84;LEU A 170;LEU A 315","None","1.43A","1skxA-4ou4A:undetectable","1skxA-4ou4A:20.00"],["1W6R_A_GNTA1536_1","ACETYLCHOLINESTERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",6,"GLY A  86;GLY A  87;GLY A  88;PHE A 216;PHE A 207;HIS A 286","None","1.00A","1w6rA-4ou4A:18.7","1w6rA-4ou4A:19.86"],["1YA4_B_CTXB2_1","CES1 PROTEIN","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"PHE A  83;GLY A  86;GLY A  87;LEU A  36;LEU A 100","None","1.34A","1ya4B-4ou4A:16.8","1ya4B-4ou4A:20.93"],["2ACE_A_ACHA998_0","ACETYLCHOLINESTERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"GLY A  87;GLY A  88;PHE A 216;PHE A 207;HIS A 286","None","0.92A","2aceA-4ou4A:18.4","2aceA-4ou4A:20.07"],["2HA4_A_ACTA544_0","ACETYLCHOLINESTERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"GLY A  87;GLY A  88;ALA A 159;PHE A 216;HIS A 286","None","0.92A","2ha4A-4ou4A:5.5","2ha4A-4ou4A:22.50"],["2HA4_B_ACTB601_0","ACETYLCHOLINESTERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"GLY A  87;GLY A  88;ALA A 159;PHE A 216;HIS A 286","None","0.94A","2ha4B-4ou4A:19.1","2ha4B-4ou4A:22.50"],["2JFA_A_RALA600_2","ESTROGEN RECEPTOR","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"ASP A 256;MET A 304;LEU A 104;HIS A  97","None","1.29A","2jfaA-4ou4A:undetectable","2jfaA-4ou4A:22.10"],["2QXS_A_RALA600_2","ESTROGEN RECEPTOR","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"ASP A 256;MET A 304;LEU A 104;HIS A  97","None","1.30A","2qxsA-4ou4A:undetectable","2qxsA-4ou4A:20.59"],["2QXS_B_RALB600_2","ESTROGEN RECEPTOR","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"ASP A 256;MET A 304;LEU A 104;HIS A  97","None","1.29A","2qxsB-4ou4A:undetectable","2qxsB-4ou4A:20.59"],["2XFH_A_CL6A1413_1","ERYTHROMYCIN B\/D C-12 HYDROXYLASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"HIS A  85;ALA A 128;ALA A 132;THR A 136","None","0.93A","2xfhA-4ou4A:undetectable","2xfhA-4ou4A:22.14"],["3BJW_G_SVRG506_1","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"VAL A 105;VAL A 106;GLY A 109;ARG A 102","None","0.96A","3bjwA-4ou4A:undetectable","3bjwA-4ou4A:15.90"],["3LCV_B_SAMB301_0","SISOMICIN-GENTAMICIN RESISTANCE METHYLASE SGM","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"ARG A  99;THR A 277;ALA A 307;ASP A 103;LEU A 104","None","1.20A","3lcvB-4ou4A:undetectable","3lcvB-4ou4A:22.71"],["3VW7_A_VPXA2001_1","PROTEINASE-ACTIVATED RECEPTOR 1, LYSOZYME","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"LEU A 208;LEU A 290;LEU A 185;ALA A 156;ALA A 165","None","1.13A","3vw7A-4ou4A:undetectable","3vw7A-4ou4A:22.07"],["3W1W_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"MET A 304;LEU A 104;LEU A 184;GLN A  40;PRO A 188","None","1.33A","3w1wB-4ou4A:2.5","3w1wB-4ou4A:20.97"],["4OK1_A_198A1001_2","ANDROGEN RECEPTOR","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"LEU A 290;ASN A 158;MET A 212;LEU A  91","None","1.01A","4ok1A-4ou4A:undetectable","4ok1A-4ou4A:22.92"],["4QVL_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","0.99A","4qvlK-4ou4A:undetectable;4qvlL-4ou4A:undetectable","4qvlK-4ou4A:21.21;4qvlL-4ou4A:21.21"],["4QVL_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","0.99A","4qvlY-4ou4A:undetectable;4qvlZ-4ou4A:undetectable","4qvlY-4ou4A:21.21;4qvlZ-4ou4A:21.21"],["4QVM_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","0.99A","4qvmK-4ou4A:undetectable;4qvmL-4ou4A:undetectable","4qvmK-4ou4A:21.21;4qvmL-4ou4A:21.21"],["4QVM_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","0.99A","4qvmY-4ou4A:undetectable;4qvmZ-4ou4A:undetectable","4qvmY-4ou4A:21.21;4qvmZ-4ou4A:21.21"],["4QVN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.02A","4qvnK-4ou4A:undetectable;4qvnL-4ou4A:undetectable","4qvnK-4ou4A:21.52;4qvnL-4ou4A:21.21"],["4QVN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.02A","4qvnY-4ou4A:undetectable;4qvnZ-4ou4A:undetectable","4qvnY-4ou4A:21.52;4qvnZ-4ou4A:21.21"],["4QVP_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.04A","4qvpK-4ou4A:undetectable;4qvpL-4ou4A:undetectable","4qvpK-4ou4A:21.21;4qvpL-4ou4A:21.21"],["4QVP_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.04A","4qvpY-4ou4A:undetectable;4qvpZ-4ou4A:undetectable","4qvpY-4ou4A:21.21;4qvpZ-4ou4A:21.21"],["4QVQ_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.04A","4qvqK-4ou4A:undetectable;4qvqL-4ou4A:undetectable","4qvqK-4ou4A:22.26;4qvqL-4ou4A:21.21"],["4QVQ_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.03A","4qvqY-4ou4A:undetectable;4qvqZ-4ou4A:undetectable","4qvqY-4ou4A:22.26;4qvqZ-4ou4A:21.21"],["4QW1_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.04A","4qw1Y-4ou4A:undetectable;4qw1Z-4ou4A:undetectable","4qw1Y-4ou4A:21.92;4qw1Z-4ou4A:21.21"],["4QW3_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","0.99A","4qw3K-4ou4A:undetectable;4qw3L-4ou4A:undetectable","4qw3K-4ou4A:21.21;4qw3L-4ou4A:21.21"],["4QW3_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","0.98A","4qw3Y-4ou4A:undetectable;4qw3Z-4ou4A:undetectable","4qw3Y-4ou4A:21.21;4qw3Z-4ou4A:21.21"],["5BXN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.01A","5bxnK-4ou4A:undetectable;5bxnL-4ou4A:undetectable","5bxnK-4ou4A:21.21;5bxnL-4ou4A:21.21"],["5BXN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.01A","5bxnY-4ou4A:undetectable;5bxnZ-4ou4A:undetectable","5bxnY-4ou4A:21.21;5bxnZ-4ou4A:21.21"],["5D0X_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.01A","5d0xK-4ou4A:undetectable;5d0xL-4ou4A:undetectable","5d0xK-4ou4A:21.65;5d0xL-4ou4A:21.21"],["5D0X_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.00A","5d0xY-4ou4A:undetectable;5d0xZ-4ou4A:undetectable","5d0xY-4ou4A:21.65;5d0xZ-4ou4A:21.21"],["5KOX_A_RFPA502_2","PENTACHLOROPHENOL 4-MONOOXYGENASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",3,"VAL A 139;ARG A 102;PRO A  71","None","0.76A","5koxA-4ou4A:undetectable","5koxA-4ou4A:24.18"],["5L5Z_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.08A","5l5zK-4ou4A:undetectable;5l5zL-4ou4A:undetectable","5l5zK-4ou4A:21.57;5l5zL-4ou4A:20.24"],["5L5Z_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"THR A 252;ALA A 253;GLY A 162;ALA A 159;ASP A 287","None","1.08A","5l5zY-4ou4A:undetectable;5l5zZ-4ou4A:undetectable","5l5zY-4ou4A:21.57;5l5zZ-4ou4A:20.24"],["5N0S_B_SAMB501_1","PEPTIDE N-METHYLTRANSFERASE","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"GLY A 143;ALA A 140;MET A  82;THR A 177","None","1.28A","5n0sB-4ou4A:undetectable","5n0sB-4ou4A:21.83"],["5NFJ_B_SAMB501_0","MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"LEU A 208;GLY A 205;LEU A  91;LEU A  24;MET A 212","None","1.02A","5nfjB-4ou4A:undetectable","5nfjB-4ou4A:20.54"],["5NFJ_C_SAMC501_0","MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",5,"LEU A 208;GLY A 205;LEU A  91;LEU A  24;MET A 212","None","1.03A","5nfjC-4ou4A:undetectable","5nfjC-4ou4A:20.54"],["5ODC_F_ACTF503_0","METHYL-VIOLOGEN REDUCING HYDROGENASE SUBUNIT A","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",4,"ARG A 102;VAL A 106;ASP A  46;LYS A 301","None","1.27A","5odcF-4ou4A:0.0","5odcF-4ou4A:21.78"],["5ODR_D_ACTD202_0","METHYL-VIOLOGEN REDUCING HYDROGENASE, SUBUNIT D","4ou4","ALPHA\/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN","Pseudomonas sp. ECU1011",3,"HIS A 142;GLU A 141;TRP A 138","None","1.14A","5odrD-4ou4A:2.4","5odrD-4ou4A:15.96"]]